$BLFS
BIOLIFE SOLUTIONS INC

2018 Form 10-K Financial Statement

#000143774919004980 Filed on March 15, 2019

View on sec.gov

Income Statement

Concept 2018 2017 Q4 2017
Revenue $19.74M $3.130M $11.02M
YoY Change 79.12% 39.11% 33.97%
Cost Of Revenue $6.217M $1.290M $4.276M
YoY Change 45.39% 46.59% 24.0%
Gross Profit $13.53M $1.840M $6.746M
YoY Change 100.49% 34.31% 41.17%
Gross Profit Margin 68.51% 58.79% 61.21%
Selling, General & Admin $8.565M $1.760M $6.609M
YoY Change 29.6% 12.1% -13.06%
% of Gross Profit 63.33% 95.65% 97.97%
Research & Development $1.298M $290.0K $1.193M
YoY Change 8.8% -32.56% -41.19%
% of Gross Profit 9.6% 15.76% 17.68%
Depreciation & Amortization $338.0K $80.00K $339.0K
YoY Change -0.29% -11.11% -7.91%
% of Gross Profit 2.5% 4.35% 5.03%
Operating Expenses $9.863M $2.060M $7.802M
YoY Change 26.42% 3.0% -18.98%
Operating Profit $3.662M -$220.0K -$1.056M
YoY Change -446.78% -65.08% -78.23%
Interest Expense $5.000K -$300.0K $190.0K
YoY Change -97.37% 400.0% 90.0%
% of Operating Profit 0.14%
Other Income/Expense, Net -$28.67M $0.00 -$1.459M
YoY Change 1864.84% -100.0% -54.26%
Pretax Income -$25.01M -$560.0K -$2.515M
YoY Change 894.23% -84.31% -68.72%
Income Tax
% Of Pretax Income
Net Earnings -$25.01M -$560.0K -$2.515M
YoY Change 894.23% -83.13% -63.42%
Net Earnings / Revenue -126.66% -17.89% -22.82%
Basic Earnings Per Share -$1.56 -$0.21
Diluted Earnings Per Share -$1.56 -$40.73K -$0.21
COMMON SHARES
Basic Shares Outstanding 16.26M 13.26M
Diluted Shares Outstanding 21.63M 13.26M

Balance Sheet

Concept 2018 2017 Q4 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.70M $6.700M $6.700M
YoY Change 358.21% 378.57% 378.57%
Cash & Equivalents $30.70M $6.663M $6.700M
Short-Term Investments
Other Short-Term Assets $400.0K $400.0K $400.0K
YoY Change 0.0% 33.33% 33.33%
Inventory $3.500M $1.847M $1.800M
Prepaid Expenses
Receivables $3.000M $1.021M $1.000M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $37.60M $9.931M $9.900M
YoY Change 279.8% 114.58% 115.22%
LONG-TERM ASSETS
Property, Plant & Equipment $1.300M $1.106M $1.100M
YoY Change 18.18% -6.85% -8.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.500M $1.070M $1.100M
YoY Change 490.91% -49.05% -47.62%
Other Assets $0.00 $0.00 $0.00
YoY Change
Total Long-Term Assets $7.900M $2.212M $2.200M
YoY Change 259.09% -32.94% -33.33%
TOTAL ASSETS
Total Short-Term Assets $37.60M $9.931M $9.900M
Total Long-Term Assets $7.900M $2.212M $2.200M
Total Assets $45.50M $12.14M $12.10M
YoY Change 276.03% 53.19% 53.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $700.0K $691.0K $700.0K
YoY Change 0.0% -2.77% 0.0%
Accrued Expenses $1.100M $201.0K $700.0K
YoY Change 57.14% 72.68% 133.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.900M $1.513M $1.500M
YoY Change 26.67% 33.52% 36.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $28.90M $46.00K $500.0K
YoY Change 5680.0% -37.5%
Total Long-Term Liabilities $28.90M $46.00K $500.0K
YoY Change 5680.0% -86.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.900M $1.513M $1.500M
Total Long-Term Liabilities $28.90M $46.00K $500.0K
Total Liabilities $30.80M $2.051M $2.100M
YoY Change 1366.67% -56.92% -56.25%
SHAREHOLDERS EQUITY
Retained Earnings -$73.96M
YoY Change 3.87%
Common Stock $84.05M
YoY Change 13.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.60M -$9.532M $10.10M
YoY Change
Total Liabilities & Shareholders Equity $45.50M $12.14M $12.10M
YoY Change 276.03% 53.19% 53.16%

Cashflow Statement

Concept 2018 2017 Q4 2017
OPERATING ACTIVITIES
Net Income -$25.01M -$560.0K -$2.515M
YoY Change 894.23% -83.13% -63.42%
Depreciation, Depletion And Amortization $338.0K $80.00K $339.0K
YoY Change -0.29% -11.11% -7.91%
Cash From Operating Activities $2.348M $810.0K $605.0K
YoY Change 288.1% -220.9% -113.98%
INVESTING ACTIVITIES
Capital Expenditures $500.0K -$50.00K $144.0K
YoY Change 247.22% -81.48% 0.33%
Acquisitions
YoY Change
Other Investing Activities -$6.000M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.500M -$50.00K -$144.0K
YoY Change 4413.89% -81.48% -136.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.15M 3.090M 4.796M
YoY Change 486.86% 215.31% 51.45%
NET CHANGE
Cash From Operating Activities 2.348M 810.0K 605.0K
Cash From Investing Activities -6.500M -50.00K -144.0K
Cash From Financing Activities 28.15M 3.090M 4.796M
Net Change In Cash 23.99M 3.850M 5.257M
YoY Change 356.42% 9525.0% -785.01%
FREE CASH FLOW
Cash From Operating Activities $2.348M $810.0K $605.0K
Capital Expenditures $500.0K -$50.00K $144.0K
Free Cash Flow $1.848M $860.0K $461.0K
YoY Change 300.87% -315.0% -110.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 blfs Adjustments To Additional Paid In Capital Sharebased Compensation Vesting Of Jv Requisite Service
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationVestingOfJvRequisiteService
22000
CY2018 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
127000
CY2017 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
127000
CY2018 blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
2609000
CY2017 blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
914000
CY2018 blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.75
CY2017 blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.18
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018 dei Entity Registrant Name
EntityRegistrantName
BIOLIFE SOLUTIONS INC
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Trading Symbol
TradingSymbol
blfs
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0000834365
CY2018 blfs Effective Income Tax Rate Reconciliation Equity Method Invesment Income Loss Amount
EffectiveIncomeTaxRateReconciliationEquityMethodInvesmentIncomeLossAmount
-141000
CY2017 blfs Effective Income Tax Rate Reconciliation Equity Method Invesment Income Loss Amount
EffectiveIncomeTaxRateReconciliationEquityMethodInvesmentIncomeLossAmount
CY2018 blfs Financing Cost And Write Off Of Deferred Debt Issuance Cost
FinancingCostAndWriteOffOfDeferredDebtIssuanceCost
CY2017 blfs Financing Cost And Write Off Of Deferred Debt Issuance Cost
FinancingCostAndWriteOffOfDeferredDebtIssuanceCost
109000
CY2018 blfs Income Tax Rate Reconciliation162m Limitation On Executive Compensation Deductibility
IncomeTaxRateReconciliation162mLimitationOnExecutiveCompensationDeductibility
296000
CY2017 blfs Income Tax Rate Reconciliation162m Limitation On Executive Compensation Deductibility
IncomeTaxRateReconciliation162mLimitationOnExecutiveCompensationDeductibility
CY2018 blfs Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-16000
CY2017 blfs Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-65000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Accumulated Amortization
LandlordfundedLeaseholdImprovementsAccumulatedAmortization
757000
CY2017Q4 blfs Landlordfunded Leasehold Improvements Accumulated Amortization
LandlordfundedLeaseholdImprovementsAccumulatedAmortization
630000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Gross
LandlordfundedLeaseholdImprovementsGross
1125000
CY2017Q4 blfs Landlordfunded Leasehold Improvements Gross
LandlordfundedLeaseholdImprovementsGross
1125000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Net
LandlordfundedLeaseholdImprovementsNet
368000
CY2017Q4 blfs Landlordfunded Leasehold Improvements Net
LandlordfundedLeaseholdImprovementsNet
495000
CY2018 blfs Legals Fees For Private Equity Transaction Incurred But Not Yet Paid
LegalsFeesForPrivateEquityTransactionIncurredButNotYetPaid
44000
CY2017 blfs Legals Fees For Private Equity Transaction Incurred But Not Yet Paid
LegalsFeesForPrivateEquityTransactionIncurredButNotYetPaid
CY2018 blfs Operating Loss Carryforwards Reduction
OperatingLossCarryforwardsReduction
2300000
CY2018 blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
12000
CY2017 blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
13000
CY2018 blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
12900000
CY2017 blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
3978000
CY2018 blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
150000
CY2017 blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
CY2018Q4 blfs Straightline Rent Adjustment
StraightlineRentAdjustment
111000
CY2017Q4 blfs Straightline Rent Adjustment
StraightlineRentAdjustment
127000
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18651678
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
115000000
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
720000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
691000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3045000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1021000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
91000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
201000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2328000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2009000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114160000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
84036000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1270000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1519000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
30000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
39000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1519000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1270000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
156000
CY2018Q4 us-gaap Assets
Assets
45467000
CY2017Q4 us-gaap Assets
Assets
12143000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
37564000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23994000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5257000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
9931000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
54000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
22000
CY2018 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2017 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
52000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6663000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1406000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30657000
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.50
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.46
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.35
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6689000
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7603000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4080000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18547406
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14021422
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18547406
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14021422
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk and business risk</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In the years <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29%</div> of our revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> of our revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer, respectively. Revenue from customers located in Canada represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> and in all other foreign countries represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total revenue during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>Revenue from customers located in Canada represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and in all other foreign countries represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16%</div> of total revenue during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>All revenue from foreign customers are denominated in United States dollars. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71%</div> of gross accounts receivable. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41%</div> of gross accounts receivable. In the years <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">88%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">77%,</div> respectively, of our revenue from CryoStor products.</div></div></div>
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6217000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4276000
CY2016Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
CY2018 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
CY2017 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4250000
CY2018Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
479000
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
622000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
130000
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
130000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
349000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
492000
CY2018Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8345000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8757000
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
42000
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
29000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7381000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8162000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
28000
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
43000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
181000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
32000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
664000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
688000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
101000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8345000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8757000
CY2017Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
225000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
24000
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
36000
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
36000
CY2018 us-gaap Depreciation
Depreciation
338000
CY2017 us-gaap Depreciation
Depreciation
339000
CY2018Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
106000
CY2017 us-gaap Dividends Preferred Stock
DividendsPreferredStock
213000
CY2018 us-gaap Dividends Preferred Stock
DividendsPreferredStock
330000
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
998000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
491000
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6548000
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1070000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
706000
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
682000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5950000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4523000
CY2018 us-gaap Gross Profit
GrossProfit
13525000
CY2017 us-gaap Gross Profit
GrossProfit
6746000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3266000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2515000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2300000
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-672000
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1005000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
5400000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-412000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3419000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
5421000
CY2018 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
CY2017 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
110000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
686000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-855000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
748000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-15000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000
CY2018 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
52000
CY2017 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-1038000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21000
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1149000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2024000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-172000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
497000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
292000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28146000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4796000
CY2018Q4 us-gaap Inventory Net
InventoryNet
3509000
CY2017Q4 us-gaap Inventory Net
InventoryNet
1847000
CY2018 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-16000
CY2017 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-65000
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
152000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1662000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
89000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
104000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
181000
CY2018 us-gaap Interest Expense
InterestExpense
5000
CY2017 us-gaap Interest Expense
InterestExpense
190000
CY2018 us-gaap Interest Paid
InterestPaid
5000
CY2017 us-gaap Interest Paid
InterestPaid
38000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1404000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
810000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1453000
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
583000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
652000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
454000
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
107000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1284000
CY2017Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1284000
CY2018Q4 us-gaap Liabilities
Liabilities
2319000
CY2017Q4 us-gaap Liabilities
Liabilities
2051000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45467000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12143000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1939000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1513000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6500000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144000
CY2018Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2018Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2018Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1657000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2348000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
605000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-2515000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
3266000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2927000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2728000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-396000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1459000
CY2018 us-gaap Notes Issued1
NotesIssued1
18000
CY2017 us-gaap Notes Issued1
NotesIssued1
39000
CY2018 us-gaap Operating Expenses
OperatingExpenses
9863000
CY2017 us-gaap Operating Expenses
OperatingExpenses
7802000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
3662000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-1056000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
1964000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
748000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
452000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
764000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
809000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
755000
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
35147000
CY2018 us-gaap Other Income
OtherIncome
281000
CY2017 us-gaap Other Income
OtherIncome
1000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46000
CY2018 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
43000
CY2017 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
9000
CY2018 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
4250000
CY2017 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
CY2018 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
436000
CY2017 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
106000
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
43000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6000000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
500000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
144000
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
339000
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
213000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
353000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
400000
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
20000000
CY2017 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3647000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3115000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1319000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1106000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
13000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
11000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1298000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1193000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71031000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73958000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19742000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11022000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2615000
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2086000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1519000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1270000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
22628
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
16300
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.95
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.76
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
181268
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
207350
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.02
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.76
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
237926
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
98439
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
279919
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.79
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.90
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
116647
CY2018 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
CY2017 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
68000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
51563
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.81
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.90
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.91
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2043402
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y215D
CY2018 us-gaap Stock Issued1
StockIssued1
36000
CY2017 us-gaap Stock Issued1
StockIssued1
36000
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4241000
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
142000
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
36000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19915000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3978000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12900000
CY2018 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
4250000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3167000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
10092000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
43148000
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div>
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5370813
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21627278
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13263881
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16256465
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13263881

Files In Submission

Name View Source Status
0001437749-19-004980-index-headers.html Edgar Link pending
0001437749-19-004980-index.html Edgar Link pending
0001437749-19-004980.txt Edgar Link pending
0001437749-19-004980-xbrl.zip Edgar Link pending
bioli20181231b_10k.htm Edgar Link pending
blfs-20181231.xml Edgar Link completed
blfs-20181231.xsd Edgar Link pending
blfs-20181231_cal.xml Edgar Link unprocessable
blfs-20181231_def.xml Edgar Link unprocessable
blfs-20181231_lab.xml Edgar Link unprocessable
blfs-20181231_pre.xml Edgar Link unprocessable
ex_137155.htm Edgar Link pending
ex_137156.htm Edgar Link pending
ex_137157.htm Edgar Link pending
ex_137158.htm Edgar Link pending
ex_137159.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending